Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,993Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M110EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M42,400,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

XBI is held by these investors:



XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48644.51view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94316.65view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1741417.65view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.365089.71view
Bebek, IvanDirector 2017-01-16Buy8,990$3.381988.17view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4117114.63view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91152.88view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.271025.68view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.3816.89view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1546953.33view

Quarterly/Annual Reports about XBI:

    News about XBI:

    Articles On GuruFocus.com
    Catasys Announces $15 Million Public Offering and NASDAQ Listing Apr 25 2017 
    Encore Capital Group to Announce First Quarter 2017 Financial Results on May 4 Apr 25 2017 
    Oasis to Announce First Quarter 2017 Results and Upcoming Conferences Apr 25 2017 
    Quality of Leadership Matters Most to Senior Talent in China, Finds Heidrick & Struggles' Latest Emp Apr 25 2017 
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Altisource Residential Corporation Apr 25 2017 
    APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. Apr 25 2017 
    RED Technologies and Ruckus Wireless Complete Interoperability Tests to Enable Advanced Wireless Ser Apr 25 2017 
    Aeromexico Reports 1Q17 Results Apr 25 2017 
    Bill Barrett Corporation Announces Pricing of Senior Notes Offering Apr 25 2017 
    IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Signet Apr 25 2017 

    More From Other Websites
    Should You Worry About A Trump Trap? Apr 25 2017
    Story Stocks from Briefing.com Apr 25 2017
    Biogen's Excellent Q1 Bodes Well for Biotech Apr 25 2017
    Trump's First 100 Days: Is the "Trump Trade" Already Dead? Apr 24 2017
    Why biotech stocks are a healthy bet in a sickly broader market Apr 20 2017
    Biotech ETFs To Consider Ahead of Earnings Season Apr 12 2017
    The Larger Aims of Obamacare: An Overview Apr 11 2017
    Tax reform could be a back door for another Republican Obamacare repeal attempt Apr 01 2017
    How to trade gridlock in DC: 4 plays Mar 30 2017
    Is Rising Consumer Sentiment Helping the Market Rally in 2017? Mar 30 2017
    5 ways to trade today's market rally Mar 28 2017
    Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher? Mar 28 2017
    What Trump can do to undermine Obamacare, now that the GOP health bill has failed Mar 27 2017
    4 ways to trade the cancelled healthcare vote Mar 24 2017
    Trump Pulls the Healthcare Bill; Market Feels the Pain Mar 24 2017
    Recent Developments for Ionis Pharmaceuticals Mar 22 2017
    Biotechnology Gets A Shot In the Arm Mar 21 2017
    Understanding Ionis Pharmaceuticals’ 2016 Revenue Stream Mar 21 2017
    Biotech firm says it’s closing in on the cancer that killed Steve Jobs Mar 20 2017
    Biogen Weighs On Biotech ETFs; Time to Bail? Mar 16 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)